• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery.

作者信息

Sharma Mitesh, Nayar Rahul, Graham Yitka, Parretti Helen M, Abbott Sally, Tahrani Abd, Miras Alexander D, Madhok Brijesh, Singhal Rishi, Mahawar Kamal

机构信息

Department of Surgery, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.

Sunderland Royal Hospital, Sunderland, SR4 7TP, UK.

出版信息

Obes Surg. 2022 Jul;32(7):2469-2470. doi: 10.1007/s11695-022-06044-6. Epub 2022 Apr 28.

DOI:10.1007/s11695-022-06044-6
PMID:35482224
Abstract
摘要

相似文献

1
Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery.
Obes Surg. 2022 Jul;32(7):2469-2470. doi: 10.1007/s11695-022-06044-6. Epub 2022 Apr 28.
2
Two cases of euglycemic diabetic ketoacidosis after bariatric surgery associated with sodium-glucose cotransporter-2 inhibitor use.两例减肥手术后出现正常血糖性糖尿病酮症酸中毒的病例，与使用钠-葡萄糖协同转运蛋白2抑制剂有关。
Obes Surg. 2021 Aug;31(8):3848-3850. doi: 10.1007/s11695-021-05391-0. Epub 2021 Apr 24.
3
Sodium-Glucose Co-transporter-2 Inhibitors Induced Diabetic Ketoacidosis in Patients Undergoing Bariatric Surgery: a Systematic Review of Case Reports and Case Series.钠-葡萄糖协同转运蛋白2抑制剂在减重手术患者中诱发糖尿病酮症酸中毒：病例报告和病例系列的系统评价
Obes Surg. 2023 Jan;33(1):339-344. doi: 10.1007/s11695-022-06368-3. Epub 2022 Nov 24.
4
Recent Developments in Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors as a Valuable Tool in the Treatment of Type 2 Diabetes Mellitus.钠-葡萄糖协同转运蛋白 2（SGLT2）抑制剂在 2 型糖尿病治疗中的最新进展：一种有价值的治疗工具。
Mini Rev Med Chem. 2020;20(3):170-182. doi: 10.2174/1389557519666191009163519.
5
[Research progress of sodium-glucose co-transporter 2 inhibitors for treatment of type 2 diabetes].钠-葡萄糖协同转运蛋白2抑制剂治疗2型糖尿病的研究进展
Yao Xue Xue Bao. 2012 Jun;47(6):716-24.
6
Adding Sodium-Glucose Co-Transporter 2 Inhibitors to Sulfonylureas and Risk of Hypoglycemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.添加钠-葡萄糖协同转运蛋白 2 抑制剂与磺酰脲类药物联合应用与低血糖风险：一项随机对照试验的系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2021 Oct 21;12:713192. doi: 10.3389/fendo.2021.713192. eCollection 2021.
7
Advances in Pharmacotherapeutics, Metabolic Surgery, and Technology for Diabetes.
Endocrinol Metab Clin North Am. 2021 Sep;50(3):457-474. doi: 10.1016/j.ecl.2021.05.009.
8
The bark giving diabetes therapy some bite: the SGLT inhibitors.树皮为糖尿病治疗带来新突破：钠-葡萄糖协同转运蛋白抑制剂。
Diabetologia. 2018 Oct;61(10):2075-2078. doi: 10.1007/s00125-018-4673-4.
9
Meta-analysis of the hallmark cardiovascular and renal outcome trials addressing the risk for respiratory tract infections with sodium-glucose co-transporter-2 inhibitors: Implications for the COVID-19 pandemic.针对钠-葡萄糖协同转运蛋白2抑制剂引起呼吸道感染风险的标志性心血管和肾脏结局试验的荟萃分析：对2019冠状病毒病大流行的启示
Diabetes Obes Metab. 2021 Jul;23(7):1696-1700. doi: 10.1111/dom.14359. Epub 2021 Mar 12.
10
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives.索格列净：首个双重 SGLT 抑制剂：当前展望与前景。
Cardiovasc Diabetol. 2019 Feb 28;18(1):20. doi: 10.1186/s12933-019-0828-y.

引用本文的文献

1
Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy Association.接受胰高血糖素样肽-1受体激动剂、葡萄糖依赖性促胰岛素多肽激动剂和钠-葡萄糖协同转运蛋白2抑制剂治疗的成人患者围手术期的择期管理：多学科共识声明：来自麻醉医师协会、英国临床糖尿病学家协会、英国肥胖与代谢外科学会、围手术期护理中心、英国住院糖尿病患者联合学会、皇家麻醉医师学院、肥胖与减重麻醉学会以及英国临床药学协会的共识声明
Anaesthesia. 2025 Apr;80(4):412-424. doi: 10.1111/anae.16541. Epub 2025 Jan 9.

本文引用的文献

1
Euglycemic Diabetic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor Use Post-Bariatric Surgery: A Brief Review of the Literature.减重手术后使用钠-葡萄糖协同转运蛋白2抑制剂导致的正常血糖性糖尿病酮症酸中毒：文献综述
Cureus. 2020 Oct 10;12(10):e10878. doi: 10.7759/cureus.10878.